2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Ewing's Sarcoma: new trials by email Literature Review of Ewing's Sarcoma trials Research Report on Ewing's Sarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study in Localized and Disseminated Ewing Sarcoma Zoledronic acid, Busulfan, Treosulfan - Ewing's Sarcoma | Phase 3 | Completed | University Hospital Muenster | 907 | 2009-10-01 | 2019-10-22 |
| Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma Standard treatment (as per protocol ISG SSG III), Intensified chemotherapy - Ewing's Sarcoma | Phase 3 | Completed | Italian Sarcoma Group | 278 | 2009-01-22 | 2022-09-19 |
Sarcoma, Ewing (2) · Neoplasm Metastasis (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Bone Tissue (2) · Neoplasms, Connective Tissue (2) · Neoplasms, Connective and Soft Tissue (2) · Osteosarcoma (2) · Sarcoma (2) · Neoplastic Processes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Busulfan (2) · Cyclophosphamide (1) · Dactinomycin (1) · Diphosphonates (1) · Doxorubicin (1) · Etoposide (1) · Ifosfamide (1) · Melphalan (1) · Vincristine (1) · Zoledronic Acid (1) · treosulfan (1)
Italian Sarcoma Group (1) · University Hospital Muenster (1)
Germany (1) · Italy (1)
Alan W Craft, Prof Sir MD (1) · Roberto Luksch, MD (1) · Uta Dirksen, Prof MD (1)
PMID 26271204, PMID 31553693, PMID 35427190, PMID 38524902, PMID 39796745, PMID 39833645
2008 (1)